journal article·2018-11-12

Highly Bioactive SDF-1α Delivery from Low-Melting-Point, Biodegradable Polymer Microspheres

Dimitra A. Louka, Nathan Holwell, Brandon H. Thomas, Fei Chen, Brian G. Amsden

Publisher page

Abstract

Aliphatic polyester biodegradable microspheres have been extensively studied for controlled and minimally invasive in situ protein delivery. However, they are commonly characterized by protein denaturation via acidic polyester degradation products, whereas their supraphysiologic modulus contributes to the inflammatory response upon implantation. To address these limitations, low-melting-point poly(ε-caprolactone-co-glycolide)-b-poly(ethylene glycol)-b-poly(ε-caprolactone-co-glycolide) (PEG-(PCG)2) copolymers were prepared and characterized for their ability to release bioactive stromal-derived factor-1α (SDF-1α) as a representative therapeutic protein. The PEG molecular weight was chosen such that it would be crystalline at room temperature to promote easy handling of the microspheres, whereas the molecular weight and composition of the hydrophobic PCG blocks were adjusted to ensure the polymer was a viscous amorphous liquid at 37 °C. Microspheres prepared from the triblock copolymers completely degraded within 8 weeks in vitro with a minor decrease in microenvironmental pH. A prolonged release of SDF-1α was observed with its bioactivity highly retained after encapsulation and release.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Advanced Drug Delivery Systems · RNA Interference and Gene Delivery · Hydrogels: synthesis, properties, applications

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Chemical Engineering, Queen’s University, Kingston, Ontario K7L 3N6, Canada

Funding

Natural Sciences and Engineering Research Council of Canada · Heart and Stroke Foundation of Canada

References (52)

Show source-provided references
1. 10.1038/nrd169510.1038/nrd1695 ↗
2. 10.1002/jps.2301810.1002/jps.23018 ↗
3. 10.1016/j.ejpb.2015.06.00810.1016/j.ejpb.2015.06.008 ↗
4. 10.1016/j.jconrel.2015.10.01210.1016/j.jconrel.2015.10.012 ↗
5. 10.1016/S0142-9612(00)00101-010.1016/S0142-9612(00)00101-0 ↗
6. 10.1016/j.addr.2016.03.01210.1016/j.addr.2016.03.012 ↗
7. 10.1016/S0168-3659(96)01496-410.1016/S0168-3659(96)01496-4 ↗
8. 10.3109/0265204980900825310.3109/02652049809008253 ↗
9. 10.1211/00223570276008900910.1211/002235702760089009 ↗
10. 10.1517/1742524080268016910.1517/17425240802680169 ↗
11. 10.1016/j.ijpharm.2007.11.01210.1016/j.ijpharm.2007.11.012 ↗
12. 10.1016/0168-3659(91)90131-V10.1016/0168-3659(91)90131-V ↗
13. 10.1038/7191610.1038/71916 ↗
14. 10.1016/S0142-9612(00)00101-010.1016/S0142-9612(00)00101-0 ↗
15. 10.1002/1097-4636(20010615)55:4<512::AID-JBM1044>3.0.CO;2-N10.1002/1097-4636(20010615)55:4<512::AID-JBM1044>3.0.CO;2-N ↗
16. 10.1089/ten.teb.2010.052010.1089/ten.teb.2010.0520 ↗
17. 10.1109/58.48447810.1109/58.484478 ↗
18. 10.1007/BF0070124010.1007/BF00701240 ↗
19. 10.1002/term.410.1002/term.4 ↗
20. 10.1016/j.jconrel.2011.10.01510.1016/j.jconrel.2011.10.015 ↗
21. 10.1021/bm034457n10.1021/bm034457n ↗
22. Bezwada, R.; Arnold, S. Liquid absorbable copolymers for parenteral applications. United States patent 5 631 015, 1997.
23. 10.1021/ma00008a00810.1021/ma00008a008 ↗
24. 10.1002/mabi.20090046510.1002/mabi.200900465 ↗
25. Perrin D. · 1998 · 3
26. Polyethylene Glycols; Dow Chemical Company: Midland, MI, 2011; pp 1–12.
27. 10.1089/ten.tea.2008.034810.1089/ten.tea.2008.0348 ↗
28. 10.1016/j.ijpharm.2009.12.06310.1016/j.ijpharm.2009.12.063 ↗
29. 10.1634/stemcells.2007-018010.1634/stemcells.2007-0180 ↗
30. 10.1016/S0301-472X(02)00883-410.1016/S0301-472X(02)00883-4 ↗
31. 10.1002/jcb.2231510.1002/jcb.22315 ↗
32. 10.1021/bm049459210.1021/bm0494592 ↗
33. 10.1016/0014-3057(72)90109-710.1016/0014-3057(72)90109-7 ↗
34. 10.1016/S0168-3659(96)01483-610.1016/S0168-3659(96)01483-6 ↗
35. 10.1007/s11095-008-9594-310.1007/s11095-008-9594-3 ↗
36. 10.1016/j.jconrel.2004.07.02910.1016/j.jconrel.2004.07.029 ↗
37. Kijima T. · Cancer Res. · 2002 · 62 · 6304
38. Sperling L. · 1992
39. Chiao C. · 1995 · 2 · 1660
40. 10.1002/(SICI)1097-4636(1999)48:3<342::AID-JBM20>3.0.CO;2-710.1002/(SICI)1097-4636(1999)48:3<342::AID-JBM20>3.0.CO;2-7 ↗
41. 10.1016/S0021-9673(00)88456-310.1016/S0021-9673(00)88456-3 ↗
42. 10.1016/j.biomaterials.2014.02.00810.1016/j.biomaterials.2014.02.008 ↗
43. 10.1093/emboj/16.23.699610.1093/emboj/16.23.6996 ↗
44. 10.1016/S0378-5173(00)00423-310.1016/S0378-5173(00)00423-3 ↗
45. 10.1016/j.ejpb.2006.09.00810.1016/j.ejpb.2006.09.008 ↗
46. 10.1016/j.ejpb.2013.04.00910.1016/j.ejpb.2013.04.009 ↗
47. 10.1016/j.ejpb.2009.11.01210.1016/j.ejpb.2009.11.012 ↗
48. Crank J. · 1979
49. 10.1110/ps.04121950510.1110/ps.041219505 ↗
50. Salgin S. · Int. J. Electrochem Sci. · 2012 · 7 · 1240410.1016/S1452-3981(23)16554-0 ↗
51. 10.19261/cjm.2014.09(2).1510.19261/cjm.2014.09(2).15 ↗
52. 10.1016/j.foodhyd.2017.08.01610.1016/j.foodhyd.2017.08.016 ↗